[Adams M, Mahringer A, Kunert O, Fricker G, Efferth T, Bauer R. (2007). Cytotoxicity and p-glycoprotein modulating eff ects of quinolones and indoloquinazolines from the Chinese herb Evodia rutaecarpa. Planta Med 73: 1554-1557.]Search in Google Scholar
[Asoh K, Kohchi M, Hyoudoh I, Ohtsuka T, Masubuchi M, Kawasaki K, Ebiike H, Shiratori Y, Fukami T, Kondoh O, Tsukaguchi T, Ishii N, Aoki Y, Shimma N, Sakaitani M. (2009). Synthesis and structure-activity relationships of novel benzofuran farnesyltransferase inhibitors. Bioorg Med Chem Lett 19: 1753-1757.]Search in Google Scholar
[Azema J, Guidetti B, Dewelle J, Le Calve B, Mijatovic T, Korolyov A, Vaysse J, Malet-Martino M, Martino R, Kiss R. (2009). 7-((4-Substituted)piperazin-1-yl) derivatives of ciprofl oxacin: Synthesis and in vitro biological evaluation as potential antitumor agents. Bioorg Med Chem 17: 5396-5407.]Search in Google Scholar
[Barbieriková Z, Bella M, Lietava J, Dvoranová D, Staško A, Füzik T, Milata V, Jantová S, Brezová V. (2011a). Spectroscopic characterization and photoinduced processes of 4-oxoquinoline derivatives. J Photochem Photobiol A: Chemistry 224: 123-134.10.1016/j.jphotochem.2011.09.015]Search in Google Scholar
[Barbierikova Z, Bella M, Kučerák J, Milata V, Jantová S, Dvoranová D, Veselá M, Staško A, Brezová V. (2011b). Photoinduced Superoxide Radical Anion and Singlet Oxygen Generation in the Presence of Novel Selenadiazoloquinolones (An EPR Study). Photochem Photobiol 87: 32-44.10.1111/j.1751-1097.2010.00832.x21073477]Search in Google Scholar
[Barbieriková Z, Bella, M, Sekeráková Ľ, Lietava J, Bobeničová M, Dvoranová D, Milata V, Sádecká J, Mercheková D, Topoľská D, Heizer T, Hudec R, Czimerová A, Jantová S, Brezová V. (2013). Spectroscopic characterization, photoinduced processes and cytotoxic properties of substituted N-ethyl selenadiazoloquinolones. J Phys Org Chem 26: 565-574.]Search in Google Scholar
[Bella M, Milata V. (2014). Synthesis of 9-ethyl[1,2,5]selenadiazolo[3,4-h]quinolones by the application of modifi ed Gould-Jacobs reaction to N-ethyl-2,1,3-benzoselenadiazol-4-amine. Arcivoc (v), 181-198.]Search in Google Scholar
[Dalhoff A, (2005). Immunomodulatory activities of fl uoroquinolones. Infection 33: 55-70. Dalhoff A, Shalit I. (2003). Immunomodulatory eff ects of quinolones. Lancet Infect. Dis. 3: 359-371.]Search in Google Scholar
[Darque A, Dumetre A, Hutter S, Casano G, Robin M, Pannecouque C, Azas N. (2009). Synthesis and biological evaluation of new heterocyclic quinolinones as anti-parasite and anti-HIV drug candidates. Bioorg Med Chem Lett 19: 5962-5964.]Search in Google Scholar
[Drlica K, Zhao X. (1997). DNA gyrase, topoisomerase IV, and the 4-quinolones. Microbiol Mol Biol Rev 61: 377-392.]Search in Google Scholar
[Drygin D, Siddiqui-Jain A, O’Brien S, Schwaebe M, Lin A, Bliesath J, Ho C, Proffi tt C, Trent K, Whitten J, Lim J, Von Hoff D, Anderes K, Rice W. (2009). Anticancer activity of CX-3543: a direct inhibitor of rRNA biogenesis. Cancer Res 69: 7653-7661.]Search in Google Scholar
[Foroumadi A, Emami S, Rajabalian S, Badinloo M, Mohammadhosseini N, Shafiee A. (2009). N-Substituted piperazinyl quinolones as potential cytotoxic agents: structure-activity relationships study. Biomed Pharmacother 63: 216-220.]Search in Google Scholar
[George S, Pili R. (2013). Tasquinimod: a novel angiogenesis inhibitor-development in prostate cancer. Curr Oncol Rep 15: 65-68.]Search in Google Scholar
[Golub A, Yakovenko O, Bdzhola V, Sapelkin V, Zien P, Yarmoluk S. (2006). Evaluation of 3-carboxy-4(1H)-quinolones as inhibitors of human protein kinase CK2. J Med Chem 49: 6443-6450.]Search in Google Scholar
[Hadjeri M, Peiller E, Beney C, Deka N, Lawson M, Dumontet C, Boumendjel A, (2004). Antimitotic activity of 5-hydroxy-7-methoxy-2-phenyl-4-quinolones. J Med Chem 47: 4964-4970.]Search in Google Scholar
[Huang L, Hsieh M, Teng C, Lee K, Kuo S. (1998). Synthesis and antiplatelet activity of phenyl quinolones. Bioorg Med Chem 6: 1657-1662.]Search in Google Scholar
[Chang Y, Yang J, Kuo S, Chung J. (2009). Induction of mitotic arrest and apoptosis by a novel synthetic quinolone analogue, CWC-8, via intrinsic and extrinsic apoptotic pathways in human osteogenic sarcoma U-2 OS cells. Anticancer Res 29: 3139-3148.]Search in Google Scholar
[Chou L., Yang J, Huang L, Wu H, Lu C, Chiang J, Chen K, Kuo S, Chung J. (2009). The synthesized 2-(2-fl uorophenyl)-6,7-methylenedioxyquinolin-4-one (CHM-1) promoted G2/M arrest through inhibition of CDK1 and induced apoptosis through the mitochondrial-dependent pathway in CT-26 murine colorectal adenocarcinoma cells. J Gastroenterol 44: 1055-1063.]Search in Google Scholar
[Chung DT, Tsai CY, Chen SJ, Chang LW, King CHR, Hsu CH, Chiu KM, Tan HC, Chang YT, Hsu MC. (2010). Multiple-dose safety, tolerability, and pharmacokinetics of oral nemonoxacin (TG-873870) in healthy volunteers. Antimicrobiol Agents Chemother 54: 411-417.]Search in Google Scholar
[Jantová S, Letašiová S, Koňariková K, Milata V, Brezová V. (2010). Eff ect of new synthetically prepared quinolone ethyl-1,4-dihydro-8-nitro-4-oxoquinoline-3-carboxylate on human leukemia cell line HL-60 without/with presence of UVA irradiation. Acta Chimica Slovaca 3: 51-72.]Search in Google Scholar
[Jantová S, Koňariková K, Letašiová S, Paulovičová E, Milata V, Brezová V. (2011). Photochemical and phototoxic properties of ethyl 1,4-dihydro-8- nitro-4-oxoquinoline-3-carboxylate, a new quinolone derivative. J Photochem Photobiol B - Biology 102: 77-91.]Search in Google Scholar
[Jantová S, Mrvová N, Hudec R, Sedlák J, Pánik M, Milata V. (2016a) Pro-apoptotic eff ect of new quinolone 7- ethyl 9-ethyl-6-oxo-6,9-dihydro[1,2,5] selenadiazolo[3,4-h]quinoline-7-carboxylate on cervical cancer cell line HeLa alone/with UVA irradiation. Toxicol in Vitro 33: 35-44.10.1016/j.tiv.2016.02.01226916084]Search in Google Scholar
[Jantová S, Paulovičová E, Paulovičová L, Topoľská D, Pánik M, Milata V. (2016b) The eff ects of novel selenadiazoloquinolone derivative on cancer cell proliferation, apoptosis and immunomodulatory activities. Cell Biol Toxicol [Accepted in Press].]Search in Google Scholar
[Khodursky A, Zechiedrich E, Cozzarelli N. (1995). Topoisomerase IV is a target of quinolones in Escherichia coli. Proc Nat Acad Sci USA 92: 11801-11805.]Search in Google Scholar
[Letašiová S, Jantová S, Čipák Ľ, Múčková M. (2006). Berberine-antiproliferative activity in vitro and induction of apoptosis/necrosis of the U937 and B16 cells. Cancer Lett 239: 254-262.]Search in Google Scholar
[Medeiros B, Landau H, Morrow M, Lockerbie R, Pitts T, Eckhardt S. (2007). The farnesyl transferase inhibitor, tipifarnib, is a potent inhibitor of the MDR1 gene product, P-glycoprotein, and demonstrates signifi cant cytotoxic synergism against human leukemia cell lines. Leukemia 21(4): 739-46.]Search in Google Scholar
[Meyer E, Schwab F, Gastmeier P, Ruden H, Heininger A. (2007). Antifungal use in intensive care units. J Antimicrobiol Chemother 60: 619-624.]Search in Google Scholar
[Oriel J. (1989). Use of quinolones in chlamydial infection. Rev Infect Dis 11: S1273-S1276.]Search in Google Scholar
[Riesbeck K. (2002). Immunomodulating activity of quinolones: review. J Chemother 14: 3-12.]Search in Google Scholar
[Santos F, Abreu P, Castro H, Paixão I, Cirne-Santos C, Giongo V, Barbosa J, Simonetti B, Garrido V, Bou-Habib D, Silva D, Batalha P, Temerozo J, Souza T, Nogueira C, Cunha A, Rodrigues C, Ferreira V, de Souza M. (2009). Synthesis, antiviral activity and molecular modeling of oxoquinoline derivatives. Bioorg Med Chem 17: 5476-5481.]Search in Google Scholar
[Sharma PC, Jain A, Jain S. (2009). Fluoroquinolone antibacterials: a review on chemistry, microbiology and therapeutic prospects. Acta Pol Pharm 66: 587-604.]Search in Google Scholar
[Sheng Z, Cao X, Peng S, Wang C, Li Q, Wang Y, Liu M. (2008). Ofl oxacin induces apoptosis in microencapsulated juvenile rabbit chondrocytes by caspase-8-dependent mitochondrial pathway. Toxicol Appl Pharmacol 226: 119-127.]Search in Google Scholar
[Sokolova G, Kunichan AD, Lazareva YV. (2009). Levofl oxacin (Tavanic) in complex therapy of tuberculosis. Antibiot Khimioter 54: 31-37.]Search in Google Scholar
[Tawfik AF, Shoeb HA, Bishop SJ, Al-Shammary FJ, Shbl AM. (1990). Infl uence of new quinolones on normal immune capabilities. J Chemother 2: 300-3005.]Search in Google Scholar
[Vinayaka AC, Sadashiva MP, Wu X, Biryukov SS, Stoute JA, Rangappa KS, Gowda DC. (2014). Facile synthesis of antimalarial odiazoloquinolone on fi - broblasts and skin model 1,2-disubstituted 4-quinolones from 1,3-bisarylmonothio-1,3-diketones. Org Biomol Chem 12: 8555-8561.]Search in Google Scholar
[Xia Y, Yang Z, Xia P, Hackl T, Hamel E, Mauger A, Wu J, Lee K. (2001). Antitumoragents. 211. Fluorinated 2-phenyl-4-quinolone derivatives as antimitotic antitumor agents. J Med Chem 44: 3932-3936.]Search in Google Scholar
[Xiao ZP, Li HQ, Shi L, Lv PC, Song ZC, Zhu HL. (2008). Synthesis, antiproliferative activity, and structure-activity relationships of 3-aryl-1H-quinolin-4- ones. Chem Med Chem 3: 1077-1082.]Search in Google Scholar
[Yamashita Y, Ashizawa T, Morimoto M, Hosomi J, Nakano H. (1992). Antitumor quinolones with mammalian topoisomerase II mediated DNA cleavage activity. Cancer Res 52: 2818-2822.]Search in Google Scholar
[You Q, Li Z, Huang C, Yang Q, Wang X, Guo Q, Chen X, He X, Li T, Chern J. (2009). Discovery of a novel series of quinolone and naphthyridine derivatives as potential topoisomerase I inhibitors by Scaff old modifi cation. J Med Chem 52: 5649-5661. ]Search in Google Scholar
